Early Conversion from Tacrolimus to Belatacept in a Highly Sensitized Renal Allograft Recipient with Calcineurin Inhibitor-Induced de novo Post-Transplant Hemolytic Uremic Syndrome

Early Conversion from Tacrolimus to Belatacept in a Highly Sensitized Renal Allograft Recipient with Calcineurin Inhibitor-Induced de novo Post-Transplant Hemolytic Uremic Syndrome

Background: Kidney transplantation is the first-line therapy for patients with end-stage renal disease since it offers greater long-term survival and improved quality of life when compared to dialysis. The advent of calcineurin inhibitor (CNI)-based maintenance immunosuppression has led to a clinica...

Full description

Bibliographic Details
Main Authors: Vasishta S. Tatapudi, Bonnie E. Lonze, Ming Wu, Robert A. Montgomery
Format: Article
Language:English
Published: Karger Publishers 2018-01-01
Series:Case Reports in Nephrology and Dialysis
Subjects:
Tacrolimus
Belatacept
Hemolytic uremic syndrome
Online Access:https://www.karger.com/Article/FullText/486158

Similar Items

Similar Items